Crashes are an occupational hazard in professional cycling but Team Sky can now treat any cut, scratch or graze to the highest possible standard after forming a partnership with Systagenix Wound Management.
Systagenix are the team's official wound care supplier and will offer the latest wound care technology and professional advice, with cutting edge products, including Adaptic Touch, Tielle, Silvercel, Non-Adherent and Promogran.
Systagenix will help improve the riders' recovery times and ensure they are in the best possible condition for every ride.
Team Sky's doctor Richard Freeman has long been an admirer of the services Systagenix offer and is delighted the partnership has come to fruition. He said: "The riders and carers are all very impressed with the support from Systagenix. In particular, the Adaptic Touch, Tielle and Bioclusive products are proving to be excellent - they are adhesive whilst also having the necessary flexibility around moving joints. We've had some really impressive healing times using Adaptic Touch and the Tielle family for road rash."
Team principal Dave Brailsford agrees: "We are delighted to be working with Systagenix Wound Management. Competitive cycling is a highly-pressured sport and brings with it many challenges and injury risks and we are fortunate to have found the perfect partner in case injury occurs."
The partnership marks a significant move for Systagenix and Vice President Global Marketing Paolo Di Vincenzo added: "We are delighted to be partnering with Team Sky, whose values and mission are synergistic with our own.
"The team's professionalism and performance-based culture are inspirational and again aligned to our own as we both strive to deliver optimum performances in our respective environments."
"We are committed to providing the team with innovative products and in-depth technical support to maximise riders' recovery times. Our experience and understanding of wound healing will give Team Sky the confidence that they are receiving the most advanced wound care treatments available."